Next Generation Sequencing Market Report 2026

Next Generation Sequencing Market Overview

• Next Generation Sequencing market size has reached to $14.2 billion in 2025 • Expected to grow to $28.59 billion in 2030 at a compound annual growth rate (CAGR) of 15.1% • Growth Driver: Rising Demand For Personalized Medicine Fuels Next Generation Sequencing Market Growth • Market Trend: Innovations In Sequencing Technology Enable Simultaneous Long And Short Read Analysis On One Instrument • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Next Generation Sequencing Market?

Next-generation sequencing is a sequencing technology that offers ultra-high throughput, scalability, and speed. The technology is used to determine the genetic variation associated with diseases or other biological phenomena. The main products in the next-generation sequencing market are NextSeq systems, MiniSeq systems, NovaSeq systems, iSeq 100 systems, ion PGM Systems, Ion Proton systems, ion GeneStudio S5 systems, PacBio RS II Systems, sequel systems, and others. The MiniSeq system merges load-and-go operation with an intuitive user interface for a fast, easy NGS workflow. The MiniSeq System integrates clonal amplification, sequencing through synthesis, and base calling into a single benchtop instrument, preventing the requirement for additional equipment. The various technologies in next-generation sequencing are sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other sequencing technologies that are used in diagnostics, drug discovery, and other applications.

What Is The Next Generation Sequencing Market Growth Forecast?

The next generation sequencing market size is expected to see rapid growth in the next few years. It will grow to $28.59 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to increasing adoption of precision medicine initiatives, rising investments in population genomics studies, expansion of NGS in oncology diagnostics, growing demand for rapid sequencing solutions, increasing integration of sequencing data with clinical decision systems. Major trends in the forecast period include increasing adoption of high-throughput sequencing platforms, rising demand for clinical diagnostic sequencing, growing integration of ai-based bioinformatics tools, expansion of targeted and personalized medicine applications, enhanced focus on cost-effective sequencing workflows.

Global Next Generation Sequencing Market Segmentation

1) By Product: Instruments, Reagents And Kits, Software 2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing, Other Sequencing Technologies 3) By Application: Diagnostics, Drug Discovery, Other Applications Subsegments: 1) By Instruments: Sequencing Systems, Library Preparation Instruments, Quality Control Instruments 2) By Reagents And Kits: Sequencing Reagents, Library Preparation Kits, Amplification Kits 3) By Software: Data Analysis Software, Bioinformatics Software, Workflow Management Software

What Is The Driver Of The Next Generation Sequencing Market?

The increasing demand for personalized medicine is expected to propel the growth of the next-generation sequencing market going forward. Personalized medicine, also known as precision medicine, is an innovative approach to medical treatment and healthcare that takes into account an individual's unique genetic, environmental, and lifestyle factors to tailor medical decisions and treatments. Next-generation sequencing is a foundational technology in personalized medicine, allowing for the precise assessment of an individual's genetic makeup and the development of tailored healthcare strategies. For instance, in February 2024, according to the Personalised Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from 6 in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the next generation sequencing industry.

Key Players In The Global Next Generation Sequencing Market

Major companies operating in the next generation sequencing market are Illumina Inc, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Oxford Nanopore Technologies Ltd, QIAGEN NV, Agilent Technologies Inc, PerkinElmer Inc, BGI Group, 10x Genomics Inc, Takara Bio Inc, New England Biolabs Inc, Twist Bioscience Corp, Element Biosciences Inc, Ultima Genomics Inc, SeqWell Inc, Integrated DNA Technologies Inc, LGC Limited, Bio‑Rad Laboratories Inc, Zymo Research Corporation, NimaGen BV

Global Next Generation Sequencing Market Trends and Insights

Major companies operating in the next-generation sequencing market are focusing on developing advanced solutions such as hybrid long- and short-read sequencing to enhance genomic resolution and accuracy. Hybrid long- and short-read sequencing combines the high throughput and low error rates of short reads with the structural insight and coverage benefits of long reads. For instance, in March 2023, Illumina, a US-based biotechnology company, launched the Illumina Complete Long Read Prep, Human assay featuring its novel Complete Long Read technology. The assay enables both long- and short-read data on the same Illumina instrument and is specifically compatible with NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 systems. Its key features include a simpler workflow with drastically reduced DNA input requirements compared to other long read platforms, integration of Illumina sequencing-by-synthesis (SBS) chemistry with DRAGEN secondary analysis for highly accurate whole-genome sequencing, access to hard to map, challenging genic regions, and a promotional price of US $1,350 per genome (on NovaSeq X Plus with a 25B flow cell), including long- and short-read library prep, sequencing, and cloud analysis.

What Are Latest Mergers And Acquisitions In The Next Generation Sequencing Market?

In September 2025, SeqOne, a France-based provider of AI-powered genomic analysis platforms, acquired Congenica for an undisclosed amount. Through this acquisition, SeqOne aims to integrate its AI-driven Next-Generation Sequencing (NGS) capabilities with Congenica’s clinical decision support and genomic interpretation technologies, thereby advancing its global leadership in AI-powered genomic medicine and accelerating the delivery of precise, personalized diagnostics. Congenica is a UK-based digital health company that offers clinical decision-support solutions and genomic interpretation services to hospitals and research institutions worldwide.

Regional Outlook

North America was the largest region in the next generation sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Next Generation Sequencing Market?

The next generation sequencing market consits of sales of genetic sequencing equipment with advanced features and technologies such as ion semiconductor sequencing, nano-pore sequencing, single-molecule real-time sequencing, and other technologies that are used for next generation sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.